Quantifying Gene Effects on Hepatic Cancer in Vivo

体内量化基因对肝癌的影响

• 批准号: 7046088
• 负责人: ERIC P SANDGREN
• 金额: $ 7.22万
• 依托单位: UNIVERSITY OF WISCONSIN-MADISON
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-04-15 至 2006-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7046088
• 关键词: carcinogenesis; cell proliferation; cell transplantation; disease /disorder model; gene environment interaction; gene expression; gene interaction; gene targeting; genetically modified animals; laboratory mouse; laboratory rat; liver cells; liver neoplasms; microarray technology; model design /development; molecular oncology; neoplasm /cancer genetics; oncogenes; p53 gene /protein

DESCRIPTION (provided by applicant): The overall goal of this proposed research is to assign a role in hepatocarcinogenesis to each of several genetic changes commonly identified in human and/or mouse liver tumors. To accomplish this objective, a newly developed, novel in vivo assay system is employed, the comparative hepatocyte growth assay. As starting material, this assay uses genetically modified mice generated by standard transgenic or gene-targeting methodologies. Hepatocytes are isolated from these mice, and then transplanted into liver of specially designed recipient mice. Evaluation of the subsequent clonal growth of donor cells in the new host environment allows quantification of the influence of single or combined genetic modifications on (1) the rate at which hepatocytes proliferate under growth stimulatory conditions; (2) the capacity for sustained hepatocyte growth in a quiescent liver environment; and (3) the risk for hepatocyte progression to malignant transformation. Each measure reflects an important characteristic of neoplastic cells. The quantitative nature of the data provides a more refined understanding of the specific contribution of each genetic change, alone and in combination with others, to the process of liver cancer progression. The final objective is to use this system as a tool for cancer gene discovery, by correlating changes in patterns of gene expression with the changes in hepatocyte clonal growth that will be identified. This proposal has the following specific aims. Aim 1: Define cancer incidence, latency, multiplicity, histotype, and progression in mice with defined combinations of hepatocyte gene changes. Aim 2: Quantify growth alterations and transformation frequency associated with defined hepatocyte gene changes in vivo. Aim 3: Identify biological behaviors and molecular characteristics of transformed hepatocytes. Successful completion of these experiments will (1) define specific interactions between several highly relevant genetic changes (synergistic or additive complementation, or no complementation) during hepatic carcinogenesis; (2) provide a systematic and comparative evaluation of the influence of genetic and environmental alterations, selected for their relevance to liver cancer, on hepatocyte growth potential; and (3) will identify gene sets that cooperate with oncogenes during tumor progression.

描述（由申请人提供）：这项拟议研究的总体目标是将肝癌发生中的作用分配给人类和/或小鼠肝脏肿瘤中常见的几种遗传变化中的每一种。为了实现这一目标，采用了一种新开发的新型体内试验系统，即比较肝细胞生长试验。作为起始材料，该测定使用通过标准转基因或基因靶向方法产生的转基因小鼠。从这些小鼠中分离肝细胞，然后移植到特别设计的受体小鼠的肝脏中。在新的宿主环境中评价供体细胞的后续克隆生长，可以量化单一或组合遗传修饰对以下方面的影响：（1）生长刺激条件下肝细胞增殖的速率;（2）静止肝脏环境中肝细胞持续生长的能力;以及（3）肝细胞进展为恶性转化的风险。每一项测量都反映了肿瘤细胞的一个重要特征。数据的定量性质提供了对每种遗传变化单独或与其他遗传变化结合对肝癌进展过程的具体贡献的更精确的理解。最终目标是通过将基因表达模式的变化与将要识别的肝细胞克隆生长的变化相关联，使用该系统作为癌症基因发现的工具。这项建议的具体目标如下。目的1：确定具有肝细胞基因变化的小鼠的癌症发病率、潜伏期、多样性、组织型和进展。目的2：量化与体内肝细胞基因变化相关的生长变化和转化频率。目的3：鉴定转化肝细胞的生物学行为和分子特征。成功完成这些实验将（1）确定几个高度相关的遗传变化之间的特定相互作用（2）对遗传和环境改变的影响进行系统的和比较性的评价，根据其与肝癌的相关性进行选择，对肝细胞生长潜力进行评价;和（3）将识别在肿瘤进展期间与癌基因合作的基因集。